Introduction
In the past two decades, researchers have been able to generate a wide range of 3D tissues using tissueengineering strategies including biomaterials, cells and appropriate environmental cues. Some of these tissueengineered medical products (TEMPs) have also been translated to clinics for in vivo tissue repair and regeneration. Despite the emergence of tissue-engineering methods as a promising strategy for overcoming the lack of organs for transplantation, its introduction into the clinical setting is limited to mostly thin tissues such as skin. One main clinical challenge that is hampering the widespread adoption of tissue-engineering strategies is the poor cell survival particularly at the core of thick voluminous grafts . Growth of thick cellulargrafts in a static culture environment is challenged by mass transport (of oxygen, nutrients, waste products and metabolites) that solely depends on passive diffusion within a cellular-graft, which is often limited to short distances (100-200 μm) and could result in inadequate nutrient supply that is required for maintaining cell viability (Rouwkema et al., 2008) . Furthermore, static cultures do not represent the native microenvironment of most tissues. One of the key motivations behind the introduction of bioreactor systems for engineering thick tissues was to mimic the physiological scenario and recapitulate nutrient transport through blood flow in the human body. Some of the important applications of bioreactors in the field of biomedical sciences and engineering are listed in Figure   F1 1.
Bioreactors in tissue engineering
The introduction of dynamic culture conditions using bioreactor systems as compared with conventional methods of cell culture in static dishes has thus far shown significant improvement in the quality of the tissueengineered graft in terms of better cell growth (Nam et al., 2013; Wu et al., 2015; Zhang et al., 2009a,b) . In static cultures, cells are often non-uniformly loaded onto and within the scaffold, and the cellular viability and growth is not even throughout the graft. The flow regime generated within bioreactors helps to overcome the limitations of oxygen diffusion within tissue-engineered grafts, which is critical in maintaining cellular survival within the graft and uniform cellular distribution. For instance, Zhang et al. (2009b) showed high levels of cell viability within the core of human fetal mesenchymal stem cell (MSC) grafts using a biaxial rotating system as compared with a necrotic centre that was observed in static grafts. The use of a fluidized bed bioreactor to scale up the culture of liver cell biomass for a bio-artificial liver machine achieved a highly dense and viable population of cellular spheroids encapsulated in alginate beads (> 45 million cells mL À1 beads) within 11-13 days (Erro et al., 2013) . In a recent study, Nguyen et al. (2016) demonstrated that dynamic bioreactor culture supported stem cell viability and functionality throughout a human femoral sized (200 cm 3 ), engineered bone graft. Other groups have also used bioreactor systems as dynamic cell loading systems for improving seeding efficiency (Ding et al., 2008; Du et al., 2008; Kitagawa et al., 2006; Koch et al., 2010; Zhao and Ma, 2005) . Koch et al. (2010) had analysed the cell-seeding efficiency and cell distribution after varying fluid flow velocity and perfusion cycle number in a perfusion bioreactor for bone tissue engineering. They had reported cell-seeding efficiency of about 50% with the perfusion bioreactor.
The studies so far have demonstrated that dynamic bioreactor culture with improved fluid dynamics can aid in better cell seeding as well as promote tissue maturation.
In addition to providing dynamic fluid flow conditions, bioreactors have now evolved to provide a physiological biomimicking environment for the generation of artificial tissues for human transplantation. There has been increased focus on the mimicry of native microenvironment of the tissue, whether it is biological, physical, electrical or mechanical. Studies are showing that bioreactors offer excellent controlled platforms for providing such biomimicking cues resulting in functionally relevant tissue grafts. Mechanostimulation has been shown to support cellular activity and differentiation for a variety of tissue types (Ishikawa et al., 2011; Liu et al., 2013; Sakai et al., 2009; Valmikinathan et al., 2011) , hence maturing the graft to the desired extent before implantation. Bioreactors are also being used for recellularization of decellularized organs/tissues. Decellularized organs are acellular substrates of tissues and have shown promising potential in functional organ replacement (Badylak et al., 2011) . Bioreactors are being used as platforms to recellularize these decellularized tissues under appropriate physiological conditions (Ott et al., 2008; Price et al., 2010; Raredon et al., 2016) .
Bioreactors in drug discovery and implant testing
Recently, bioreactors have become more than just a platform to engineer functionally relevant, three-dimensional tissues. Beyond controlling the fate of tissue growth and development, studies have started exploring bioreactors as effective in vitro platforms for drug/implant testing with a hope to replace or reduce the use of animal models in the future. Pre-clinical animal models are required for pharmaceutical testing, implant testing, and to understand human physiology and disease biology. However, animal maintenance is time consuming, labour intensive and expensive. In consideration of the three Rs (replacement, reduction and refinement; de Vries et al., 2015) , there is a need to adopt alternative approaches to animal models and thereby pave a path for humane animal research. This has led to a growing interest towards in vitro cell-and tissue-based models that can replace or reduce the usage of animal models.
Many groups have developed 3D in vitro models with controlled cellularity, micro-architecture and environmental conditions as platforms for pharmacological testing (Kang et al., 2009; Loessner et al., 2010; Pusch et al., 2011; Subramanian et al., 2010; Zeilinger et al., 2011) . With growing interest in these 3D models, it has become essential to import the tools used in tissue engineering like dynamic bioreactor systems for developing these models, particularly 3D disease and cancer models . The most important advantage of bioreactors would be their ability to maintain tissues under controlled environments and mimic the native tissue's microenvironment, which allows us to possibly create in vitro animal models. Some studies have demonstrated the use of bioreactors for growing 3D tissues to test pharmacological agents in substitute of animal models. A study on the biology of multiple myeloma and its response to drug therapy by Ferrarini et al. (2013) utilized the commercially available RCCS ™ bioreactor to culture myeloma tissues with controlled maintenance of cells, architecture and microenvironment. The ability to sustain cellular viability and functionality for longer durations is an important factor to be considered for drug metabolism and toxicity studies. Leite et al. (2011) showed that co-culturing hepatocytes and fibroblasts under dynamic conditions within a bioreactor enabled long-term maintenance of functional cells as compared with conventional 2D monocultures and cocultures. Ishikawa et al. (2011) used the rotating wall vessel bioreactor for cultivating 3D hepatic-like tissues for the purpose of drug testing, and showed the formation of bile duct-like structures and blood vessels from fetal liver cells. More recently, Hirt et al. (2015) had shown that perfused 3D cancer tissues growth within bioreactors shared functional similarities and drug response with in vivo cancers. Further, there is also a strong need for developing better biomimetic tools to study disease models. In addition to drug testing, bioreactor platforms can be used for development of ex vivo disease models using human/animal tissues to understand biological mechanisms behind physiological conditions and disease progression. Perfusion bioreactors have been used to emulate the fluid dynamics that represent the arterial/venous parameters in order to study the arterialization of veins during artery bypass grafting (Longchamp et al., 2014; Model et al., 2014; Piola et al., 2016) . Similarly, mechanical loading bioreactors have been used to assess the biological changes upon application of complex mechanical loads on spinal tissues isolated from animals that could lead to the understanding of loading-induced progression of spinal disorders (Chan et al., 2013; Hartman et al., 2015) . In another study, a shear stress bioreactor was used to provide controlled haemodynamics to porcine aortic valves and study its role in the development of calcific valve disease (Ling et al., 2012) . In addition to ex vivo disease models, engineered tissues have also been used for understanding physiological mechanisms using bioreactor systems. An in vitro human physiological loading model of cartilage callus was developed by Hoffmann et al. (2015) to study fracture healing using a novel perfusion compression bioreactor system. The above-mentioned studies showcase the potential of bioreactors to act as effective bridges between monolayer cell cultures and animal models.
Bioreactors in clinics
With years of research successes in bioreactor cultivation of engineered tissues, commercial and clinical usage of these systems are evidently not far behind. Bioreactor has been used to apply cyclic radial strain to cells seeded on biodegradable scaffolds to produce functional vascular grafts with well-formed collagenous extracellular matrix (ECM). This was followed by detergent-based decellularization for the generation of clinically relevant decellularized, tissue-engineered vascular grafts that can be eventually stored for future use or seeded with autologous cells and implanted (Dahl et al., 2011; Niklason et al., 1999) . The studies have reached clinical trials (NCT01744418, 2012; NCT01840956, 2013; NCT01872208, 2013) , and the group's interim press release claims 100% effectiveness (Humacyte, 2013) . NeoCart is a commercial product that is currently undergoing clinical trials (Crawford et al., 2012; NCT00548119, 2007) that utilizes a bioreactor to provide conditions that mimic the low oxygen tension and pressure conditions of the knee. Cytograft Tissue Engineering is another company that has a patented bioreactor technology to enable cell sheet tissue engineering to produce vascular grafts (McAllister and L'Heureux, 2006) . The bioreactor provides a cell sheet growth module and a mandrel to roll the sheet to fabricate the engineered blood vessel. The LifeLine graft generated by the company has also been demonstrated to be clinically successful (McAllister et al., 2009; NCT00850252, 2013; Wystrychowski et al., 2011) . These studies serve as a promising start for clinical utilization of bioreactor systems for regenerative medicine applications.
Despite the promising start, we need to identify the challenges that are preventing the widespread adoption of these systems in clinics. From a clinician's perspective, certain requirements have to be met for clinical utilization of bioreactor-generated engineered tissue. We need easyto-use, safe, reproducible, automated, scalable, versatile and regulatory-compliant tissue culture systems with an ability to control and evaluate the growing tissue and microenvironment with a rapid turn-around time. Generation of 3D tissues starts with selection or fabrication of geometrically defined scaffolds, isolation of specific cell types, followed by defining the optimal culture conditions for tissue growth. Firstly, there is lack of an optimized protocol for specific type of tissue in question. Secondly, very few culture systems allow real-time sensing and control of culture conditions. Also, most tissue culture systems do not have the facility to evaluate the end product prior to tissue implantation. Further, most of the systems require manual handling of tissues, which in turn could result in variable quality of the tissues. Hence, the question we are trying to answer is what can be done in terms of bioreactor design to achieve bioreactor utility in clinics. In this review, we aim to provide a summary of key factors in the design of bioreactor systems for tissue engineering eventually enabling clinical translation of bioreactor matured grafts.
Design considerations
Three major design factors are going to be discussed in this review, starting with the latest developments in bioreactor design that allow control of physiologically relevant cues on the growing tissue. This would be followed by a brief discussion on the current trends in non-contact sensing of the bioreactor culture conditions and the associated automation features. And thirdly, the current technological advancements that enable non-invasive, qualitative and quantitative evaluation of the growing constructs would be surveyed.
In designing a bioreactor, one of the primary focuses is to evaluate the type of culture and intended application of the system. Upon conceptualizing the bioreactor design, the effectiveness of the bioreactor in achieving the specific roles can be verified using prediction methods to better understand the implications of various parameters, such as fluid flow regime, oxygen tensions, mechanical force stimulation and their influence on cellular behaviour.3D scaffolds under a particular flow condition and/or mechanical condition need to be reproducibly quantified and modelled (Hutmacher and Singh, 2008) . Using prediction methods, we can seek to understand, optimize or design bioreactor conditions to verify the intended outcome of the application of interest. These methods could predict media-related flow conditions and chemical gradients for mass transports (Devarapalli et al., 2009) , scaffold-related mechanical forces and their responses (Milan et al., 2009; Song et al., 2013) , as well as cellular adhesion, morphology, population dynamics, tissue growth, forces and other behavioural patterns (Cheng et al., 2009; Galbusera et al., 2007; Sengers et al., 2007) . For instance, Cantini et al. (2009) used computational fluid dynamic techniques to design the optimal microenvironment for co-culture of adherent bone marrow stem cells and non-adherent haematopoietic stem cells inside porous scaffolds in perfusion bioreactor, and the results predicted the effects of microchannel-provided scaffolds with different geometries on fluid-dynamics and oxygen transport. This earlystaged validation can provide cost savings in development and design of novel bioreactor and scaffold configurations, as well as help to understand scalability-related issues. For instance, Singh et al. (2005) had utilized computational methods to predict and understand the fluid flow within scaffolds inside a dynamic bioreactor system under uniaxial and biaxial rotation conditions. Their modelling showed an increase in fluid velocity within the scaffolds under biaxial mode of the dynamic bioreactor system. Subsequently, the experimental validation also showed that biaxial rotation led to a more homogeneous cellular and ECM distribution due to improved fluidics within the system (Zhang et al., 2009b (Zhang et al., , 2010a .
Another interesting idea would be the utilization of multi-chambered vessels for parametric optimization studies. In attempting to mimic the physiological niche of the tissue-of-interest, several factors and conditions such as varying concentrations and types of soluble factors, cellular density and combination of cell types, different modes and extent of mechanical stimulation and flow rate need to be optimized. Particularly for larger vessels, these studies are expensive, resource-and timeconsuming, and often hinder the progress of research. To minimize experimental variations upon optimization of multiple parameters and operate in a more timeefficient and cost-effective manner, it would be helpful to develop an array of scaled-down bioreactors within one system. Essentially, the presence of multiple chambers with separate media conditions will allow the study of effects of different intrinsic parameters (different cell sources, scaffold materials or configurations and media components) and also external factors (mechanical, fluid and electrical stimuli) concurrently in one bioreactor run. For instance, Pavesi et al. (2014) developed a multichambered device with adaptable, independent culture chambers to test various electrical stimulation protocols simultaneously for stem cell differentiation towards myocardial phenotype. Similarly, Brady et al. (2014) designed and validated a high-throughput bioreactor platform for the application of multiple magnetic fields and mechanical loading regimens simultaneously in multiple chambers with independent control for engineering functional cartilage tissues. In addition to enabling parametric optimization studies, the multi-array configuration could also be potentially used for drug and toxicology studies with disease models (Domansky et al., 2010) . This would provide time and cost savings in terms of consumables, manpower and resources, and yield faster results, hence help expedite research and development. In addition to the research studies that have incorporated bioreactors with multiple growth chambers (Cimetta et al., 2009; Domansky et al., 2010 Q3 ; Engelmayr et al., 2003; Juncosa-Melvin et al., 2006; Pavesi et al., 2014; Piola et al., 2013) , bioreactor systems with multiple chambers are also gaining commercial importance EBERS Medical Technology, 2015a; Flexcell International Corporation, 2016; Kirkstall, 2016; TA Instruments, 2015) Q4 Q5 Q6
. Once the structural design is ready, aspects such as chamber construction, biocompatibility of its material, size factors and sterility maintenance have to be decided. Concurrent with this design phase, it would be ideal to consider regulatory requirements and industry standards to save time and avoid significant re-designing. This is followed by provision of control and sensing systems for detection and maintenance of the optimal biochemical and biomechanical environment to maximize efficacy of tissue formation. A facility to image the grafts in the bioreactor environment would add value to the system in terms of evaluating real-time tissue growth and dynamics. Particularly for clinical use, the ability to generate grafts with a certain extent of reproducibility is essential for predicting a certain outcome for widespread adoption. This can be achieved by having an automated system that works on a feedback mechanism and enables reduction of manual handling and associated contamination risks. The disposability of the bioreactor chambers has also become an increasingly important consideration. It eliminates labour-intensive tasks like cleaning and storage of bioreactor parts, saves a lot of time taken for starting a bioreactor run and also in between two batches of cultures (Eibl and Eibl, 2009 ). Thus, their utility in a clinical setting will be high as they have an important role in maintaining high sterility and flexibility of usage.
In weighing the importance of each criterium, some consideration factors might add more value to a clinical set-up, while others might be of higher value in a research laboratory. For instance, introduction of multi-chambered vessels will enable concurrent optimization of parameters to be used in bioreactor. This could be a cost-effective and time-saving design idea in research labs. On the other hand, it might not add significant value in clinics where the primary aim is not concerning judicious use of resources or optimization of bioreactor parameters. And hence for clinical application, designing bioreactors with multi-chambered vessels will be less impactful. Likewise, disposability of bioreactor components will play an important role in ensuring sterility and easier starting up of bioreactor run at a clinical level, whereas it might not add tremendous value to an existing reusable system in a research lab. Thus, by comparing research use and clinical use ( Table   T1 1), it allows us to identify gaps during the phase of research as we keep in mind the overall purpose for clinical utility.
Physiological biomimicry
For making tissues of a specific organ, we need to first identify the most optimal combination of cell/scaffold/ bioreactor along with the appropriate environmental cues that include biological, chemical, physical, mechanical and/or electrical cues based on the native physiology of the specific tissue in question. At every step in this entire process, physiological biomimicry of the native tissues and the environment could result in tissues with enhanced functional properties (Abbott and Kaplan, 2015) . While biological and chemical cues for the regeneration of a specific tissue have been extensively studied and optimized over the past few decades, other types of physiologically relevant cues such as electrical and mechanical cues have also gained a lot of attention in the past few years. Stimulatory effect of electrical signals on in vivo tissue growth and regeneration has been well established in the past. Balint et al. (2013) have done an excellent review of the physiological relevance of electrical stimuli, the methods of stimulation and resulting cellular effects of electrical stimulation. Non-invasive, ultrasound stimulation has also been widely studied as a tool for tissue regeneration, especially the bones, cartilage and soft tissues (Tanaka et al., 2015) . Static cultures for tissue engineering without appropriate mechanical stimulation may result in poorly cellularized grafts, and require longer culture durations or larger initial cell numbers. By physiological mimicry of mechanical forces experienced by native tissues within the body, accelerated tissue formation has been demonstrated by an increase in proliferation and differentiation of cells. In this review, amongst the various environmental parameters to be optimized, we would like to highlight the role played by mechanical stimulation in tissue development and discuss the current trends in mechanical bioreactors for engineering tissues.
Understanding mechanical forces on organs
Mechanical forces in the human body play a role in regulating tissue growth and remodelling processes. Cells respond to mechano-stimulation by changes in cellular alignment, rate of proliferation, differentiation, migration, matrix deposition or by apoptosis. The study of mechanical induction of 2D cell cultures showed structural and functional changes like morphology, alignment, polarity, gene and protein expression (Matsugaki et al., 2013; Park et al., 2004; Xie et al., 2012) . Literature on single cell studies have aided understanding in downstream signalling events in a mechanically stimulated cell that culminates in differential gene expression, protein synthesis or release of factors, which in turn will indirectly control the aforementioned cell-fate processes (Leipzig and Athanasiou, 2008; Ofek et al., 2010; Rath et al., 2010; Wang et al., 2010) .
However, these models do not represent the native 3D environment. Tissues exhibit a hierarchical cellular arrangement based on their physiological functional role, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 which could be closely related to the mechanical forces that act on them. To engineer artificial tissues that resemble the native tissues both structurally and functionally, it would be important to provide appropriate in vitro conditions that mimic the native microenvironment of the tissue. This has clearly been neglected in our long-standing conventional methods of culturing cells in a static environment. The native biomechanical environment of different tissues in the body has been represented in Figure   F2 2. Engineering functional tissues in conjunction with the use of bioreactor systems focuses on a biomimetic approach where the mimicry of the physiological forces comes into play within the controlled environment in the bioreactor (Butler et al., 2009; Grayson et al., 2009 ). In the human body, the tissues are exposed to forces like fluid flow, compression, tension, torsion and hydrostatic pressure (Figure 2 ). Based on the location and functionality of a specific tissue, it experiences one or a combination of these forces. For example, blood vessels experience both fluid shear stresses and hydrostatic pressure, whereas cartilage tissues are mainly under compression. Various studies have shown that cells respond differently to variations in type of forces, magnitude, culture times and duration of rest periods (Robling et al., 2002; Sen et al., 2011) . Clearly, an optimal range of the variables is required for appropriate physiological tissue formation and response. While the different mechanical stimuli experienced by tissues has been summarized before (Polacheck et al., 2013) , this could be difficult to benchmark due to variations between anatomical differences physiologically and also different experimental set-ups between research studies. Thus, choosing a 'gold standard' will remain a challenge. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64   65  66  67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128 
Mechanical stimulation bioreactor
Bioreactors present an interesting platform to study mechanical forces and their concomitant effect on tissue growth and development for regenerative medicine. To mimic the physiological loading regimes, some bioreactors have incorporated mechanical loading systems to provide compression, tension, torsion forces onto the grafts. Some of the commonly applied mechanical stimuli like compression, torsion, tension and shear stresses on cell-seeded 3D scaffolds within bioreactor systems are represented in Table   T2 2. Research studies that involved compressive forces have mainly focused on engineering bone and cartilage tissues. Zong Ming et al. (2013) demonstrated that the application of cyclic compression on bone explants induced an increase in the expression of osteogenesis-related genes and proteins, resulting in enhanced mechanical properties, mineralization as compared with the unloaded controls. Liu et al. (2012) studied the effect of cyclic compression combined with perfusion on mesenchymal stromal cellsseeded polyurethane scaffolds for fibrocartilagenous differentiation. It was found that inclusion of rest periods in between bouts of cyclic compression led to (Table 2a) . In another study, MSCs were mechanically preconditioned by syringe-based pressure loading towards nucleus pulposus-like cells for intervertebral disc regeneration and loading led to upregulated gene expression of nucleus pulposus-related marker genes SOX9, COL II and ACAN (Zeng et al., 2015) . Tensile forces are more commonly experienced in muscles, tendons, ligaments, blood vessels and cardiac tissues. Nagai et al. (2012) had analysed molecular level changes like increase in ERK phosphorylation levels on application of uniaxial static strain of skeletal muscle cell-seeded scaffold. Baker et al. (2011) demonstrated an increased collagen production and fibrous gene expression on dynamic tensile loading of MSCs seeded on polycaprolactone (PCL) nanofibres. Sharifpoor et al. (2011) demonstrated higher DNA mass, better cell area coverage, better cell distribution and improved tensile mechanical properties on application of cyclic uniaxial tensile strain on smooth muscle cell (SMC)-seeded polyurethane scaffolds (Table 2b) . Torsional forces have been used in engineering ligament tissues and intervertebral discs. Scaglione et al. (2010) showed that application of torsional forces to fibroblast seeded PCL-based scaffolds that resulted in increased expression levels of collagen type I, collagen type III and tenascin C. Sawaguchi et al. (2010) demonstrated that application of torsional strains enhanced ECM synthesis and proliferation. Chan et al. (2011) showed an improved cell viability in the inner region of the disc on application of torsional forces of low magnitude that lies within the physiological range (Table 2c) . Shear is one of the most commonly studied forces in the bioreactor likely due to the mimicry of blood flow in the human body. Different groups have thoroughly reviewed the role of shear stresses in bioreactor systems and concentrating on different aspects like the current state for organ engineering (Bijonowski et al., 2013) , a specific interest on the impact of shear stresses on osteogenesis and angiogenesis (McCoy and O'Brien, 2010) and influence of dynamic shear stress in bone tissue engineering (Yeatts and Fisher, 2011) . In general, application of shear stresses on cell-seeded 3D scaffolds shows increased proliferation and ECM synthesis (Bhumiratana et al., 2011; Cheung et al., 2013; Liu et al., 2012) or differentiation (Bhumiratana et al., 2011; Maidhof et al., 2012;  Table 2d ).
In sum, the application of functionally relevant mechanical signals inside the chamber of a bioreactor has clearly demonstrated improved tissue functionality owing to the recapitulation of the native biophysical microenvironment. Although it will be a technical feat to exactly mimic the in vivo conditions per se in a bioreactor, our progress in the understanding of mechanical effects on tissue engineering is leading us closer to the development of clinically relevant engineered tissues/organs.
Sensing and automation

Sensing culture conditions
In cell and tissue culture, growth media provides the necessary nutrients for cell proliferation and/or differentiation, while metabolites and by-products such as lactate are being released into the media. The ability to systematically ascertain specific culture conditions within the bioreactor vessel and subsequently regulate a feedback response is essential for achieving effective tissue growth. Slight changes in vital parameters like dissolved O 2 , CO 2 , pH and glucose in the culture media could adversely affect the cellular functions like proliferation and differentiation. With respect to tissue culture in bioreactors, on-line monitoring of culture conditions is important to ensure accuracy and reproducibility of the bioreactor runs. Commercially available bioreactor systems possess integrated sensor systems that can perform on-line measurements of gas and metabolite levels, etc.
There are three ways of sensing bioreactor culture conditions, namely, invasive, shunt and non-invasive sensing . Shunt sensing is a simple technique where culture media would be sampled at regular intervals and measured off-line using benchtop sensors. This has obvious disadvantages of not being real-time. Direct invasive sensors that can perform on-line sensing in bioreactors are generally sterilisable/single-use, electrochemical sensors that are in contact with the culture media, mostly restricted to the media reservoir, culture media loop or inlet/outlet of bioreactor chambers (Janssen et al., 2006; Li et al., 2014; Mundargi et al., 2015) . This method is widely popular owing to the abundance in commercially available pH and DO (dissolved O 2 ) electrochemical probes. In fact, microelectrodes are not only used to measure the surrounding milieu but also inside the growing grafts to assess the conditions of cellular microenvironment (Malda et al., 2004) . The major limitation with these invasive sensors is the possible risk of contamination in addition to high costs, fouling and consumption of analytes in the culture media (Starly and Choubey, 2008) .
Utility of bioreactors in clinics necessitates contamination-free processes with real-time sensing facilities that allow automated feedback to maintain optimal conditions. Over the past few years, there has been an increasing interest in the non-invasive imaging modalities, especially luminescence-based sensors for sensing environmental conditions within the bioreactor. While direct contact is required for electrochemical sensing, it is possible to non-invasively detect fluorescence-based signals through the walls of a transparent vessel. Fluorescence-based sensing for detection of media conditions in the bioreactor started almost two decades ago (Vunjak-Novakovic et al., 1999) . A number of fluorescent dye-based adhesive patches have been developed and are available commercially that can be adhered on to transparent bioreactor vessel surfaces. Changes in fluorescence signal are detected using optical probes that are not in direct contact with the sterile culture media (Leah et al., 2005) . Papkovsky and Dmitriev (2013) have explained the working principle of these sensors in depth and reviewed the different types of these luminescence-based sensors. CellPhase®, HP5 and PSt3/PSt6 (PreSens®), RedEye® are some of the commercial fluorescent sensor patches that are suited for sensing DO/pH/metabolites inside bioreactor vessels. Some of these sensors come in single-use packages making it safe for clinical usage. Santoro et al. (2012) had used PSt3® disposable, micro-oxygen sensors to measure the oxygen levels at the inlet and outlet of a perfusion bioreactor used for engineering cartilage grafts. The consumption of oxygen in the bioreactor chamber gave an indication of the number of chondrocytes on the graft, which in turn enabled non-invasive evaluation of quantitative quality of engineered cartilage graft. Recently, Raimondi et al. (2015) demonstrated the use of SF-RPSu4® sensor foils within a miniature perfusion bioreactor system to quantify the oxygen concentrations within the tissue-engineered construct in a nondestructive way. In addition to sensor foils, microbeads and nanoparticles are also being used as oxygen-sensing systems within the tissues. In a recent study, oxygensensitive, phosphorescent microbeads were placed inside the scaffolds to non-destructively determine the oxygen levels in the centrum of the scaffold under static and dynamic culture conditions (Weyand et al., 2015) . Although these bead/nanoparticle-based sensing of metabolites within scaffolds provide valuable information, they are invasive and redundant for clinical application.
As close as we are in incorporating these useful sensing systems for clinical use, we need to address some of its limitations, including complexity of optical set-ups required for detection and lesser flexibility in aligning the set-up with dynamic, moving bioreactor parts. Nevertheless, these luminescence-based non-invasive sensors exhibit great potential for rapid sensing of environmental parameters in the bioreactor culture for clinical applications.
Automation in bioreactor systems
Sensing of the bioreactor culture conditions must be accompanied with a feedback mechanism to maintain the relevant conditions at an optimal level. And, if this feedback mechanism is automated, it would add more value for clinical usage. For that matter, right from the initial setting up of the bioreactor system to its operation, manual handling can be labour intensive, time-consuming, prone to contamination and could result in the reduction of graft reproducibility. Automation of bioreactor systems will allow better control of the bioreactor processes, provide higher efficiency and reproducibility of graft outcomes. This is an extremely important criteria to fulfil for clinical relevance of bioreactor-cultured engineered grafts. Automation not only improves productivity but also maintains consistency of the artificial tissue to be formed as well as the environment it is in. Professor Teruo Okano, one of the pioneers in the area of automation for cell culture technologies, has demonstrated the importance of an automated process control in clinical acceptance and utility of the technology. Briefly, his technology generates cell sheets that are detached from temperature-responsive cell culture-ware based on temperature changes. Unlike conventional methods that require an enzymatic reaction (Kushida et al., 2001 (Kushida et al., , 2005 Yamato and Okano, 2004) , this method of automation has significantly increased productivity, and minimized the number of procedural steps and risk of contamination during the handling of cell sheets. This technology has since progressed into the pre-clinical models for use in the repair of various tissues, such as cornea, skin, oesophagus, heart and periodontal tissue (Iwata et al., 2009; Kobayashi et al., 2013; Nishida et al., 2004; Sawa et al., 2012; Takagi et al., 2010) .
Media exchange, harvest of cellular-grafts during imaging and even transfer of the bioreactor from the incubator into the biosafety hood are potential routes for contamination. Automation of the bioreactor systems would help minimize the risk of tissue graft contamination. In addition, software and controllers that are designed for use in conjunction with these automated systems require a user-friendly interface for user's preference and for capturing real-time data with automated data processing into graphical or numerical formats. Table   T3 3 shows some examples of automated, Olmer et al. (2012) commercial bioreactor systems used with scaffolds for different applications. Automation in bioreactors has been introduced at different steps of cell culture, such as medium change, expansion, dynamic seeding of scaffolds and automated sequencing of user-defined protocols (Ding et al., 2016) . Some bioreactors have sensors to provide feedback on the culture conditions (Volkmer et al., 2012) , while others also have the ability to record, analyse and transfer data to local network.
Evaluation of engineered tissue
During the generation of artificial tissues in vitro, it would be ideal to monitor and study the extent of tissue growth, particularly in determining whether the graft is substantially mature and ready for patient implantation. Currently, most bioreactors require frequent halting of the entire dynamic process and dismantling parts of the bioreactor to harvest the cellular-grafts, which could result in contamination. The most commonly utilized techniques are scanning electron microscopy (SEM) and confocal systems for imaging 3D tissue grafts, and this is most often limited to an end-point harvest due to the post-processing and dye-staining involved. The field and depth of view of the tissue of investigation is also difficult to track due to either the limited capabilities of the imaging system or because the images have been sectioned. Having compatible imaging systems incorporated with bioreactor systems would allow real-time and non-destructive monitoring of the quality of the cellulargraft, its tissue characteristics, properties and growth dynamics. Real-time, non-invasive imaging methods reduce the source of errors and noise within the experiments in longitudinal studies, and increase the ease of handling and user convenience. They also aid in saving time and prevention of contamination of the system, which is essential especially for clinical analysis prior to implantation. In our classification of the different imaging modalities, the cultured tissue of interest may be subjected to destructive or non-destructive testing upon imaging (Table   T4 4). Various parameters that can be obtained using these imaging modalities include cellular morphology, viability and distribution, scaffold architecture, mechanical properties of the tissue graft, collagen organization, mineralization and metabolite distribution. In recent years there has been significant advancement in the various sophisticated technologies for imaging on both cellular and tissue level. Near infra-red imaging, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), single positron emission computed tomography (SPECT), positron emission tomography (PET) and confocal systems have been used for imaging different cellular processes like proliferation, angiogenesis perfusion, and apoptosis with varying levels of detection capabilities due to the differences in their depth of sample penetration. In spite of the advantages associated with real-time imaging within a bioreactor, like achievement of images with greater details, high resolution, opaque structures of scaffold architecture and cell profile in 3D under dynamic culture conditions, in situ dynamic bioreactor imaging has not gained much popularity due to the high costs involved in incorporating sophisticated imaging technologies complemented with the bioreactor and the need to maintain and miniaturize these imaging systems. The future lies in the development of a miniaturized imaging unit that could be incorporated into the bioreactor system for real-time imaging without compromising on the ease of use and bioreactor operations.
Emerging trends in clinically relevant bioreactor design and future directions
In recent years there has been a rising trend in the number of bioreactor-related studies with the introduction of a variety of new bioreactor designs for different applications. Currently available commercial systems for generation of artificial 3D tissues provide dynamic flow environment in addition to application of specific mechanical forces depending on the tissue type. Table   T5 5 summarizes a selected list of commercially available bioreactors for generating 3D tissue-engineered grafts. The table showcases the current trends in commercial bioreactor design, including provision for application of mechanical forces and availability of sensing modalities to sense culture conditions inside the bioreactor system.
In the past decade, there have been several studies that showcased the possibility of tweaking bioreactor designs to make them relevant in clinics. The three major bioreactor design factors discussed in this review will be important requirements for their future utility in hospitals. Biomimicry is a well-known strategy in tissue engineering (Grayson et al., 2009) . Several groups have reviewed the importance of studying developmental biology of tissues to aid functional tissue engineering (Liu et al., 2011; Stock and Vacanti, 2001) . Almost a decade ago, Martin and Vermette (2005) had suggested modelling bioreactors based on the natural reactor 'uterus'. Our group had developed the biaxial bioreactor system that has the ability to spin (rotate about the z-axis) and tumble (rotate about the x-axis) simultaneously, which mimics the 'fetal gyroscopic motion' inside the womb. This biaxial rotation has been reported to aid in increased mass transport through thick scaffolds leading to efficient nutrient and waste exchange (Zhang et al., 2009b) , and showed increased bone formation and greater neo-vasculogenesis in vivo (Zhang et al., 2010b) . Recently, Morgan and Black (2014) performed bioreactor studies for cardiac tissue engineering by mimicking the native biophysical environment during ventricular contraction of the heart. They demonstrated that the delayed electrical stimulation after the start of mechanical stimulation mimicking the in vivo scenario promoted generation of functional cardiac tissues in comparison to other modes of stimulation. In another study by Heher et al. (2015) , bioreactor was used to apply mechanical stimulation protocols that mimic in vivo muscle development during embryogenesis for engineering functionally relevant skeletal muscle tissues. The results demonstrated that strain led to aligned myotube formation and also temporal expression of functional genes similar to patterns observed in vivo.
While it is a commendable scientific feat to achieve a functional, in vitro tissue through bioreactor conditioning, a strong need for bioreactor-matured tissues in place of premature grafts in a clinical scenario has not been established. Firstly, there is no defined in vitro end-point for tissue maturation. There are varying degrees of maturation for each type of tissue. If we consider the bone tissue, there are four progressive stages of bone regeneration , starting from precipitation of mineralized nodules in the first stage, and the final stage is defined by formation of dense and compact lamellar bone. Secondly, even if we do specify an end-point for the tissue in question, we need to establish the superiority of highly matured tissue grafts for clinical implantation Table 4 . Destructive and non-destructive imaging modalities to evaluate tissue-engineered grafts cultured in bioreactor systems (Appel et al. 2015) Imaging 
MS, microscopy; SEM, scanning electron microscopy; TEM, transmission electron microscopy; AFM, atomic force microscopy; ECM, extracellular matrix; CT, computed tomography; PET, positron emission tomography; SPECT, single positron emission computed tomography; OCT, optical coherence tomography; MPM, multiphoton fluorescence microscopy; SHG, second harmonic generation; MR, magnetic resonance; MRI, magnetic resonance imaging; IR, infrared.
over premature grafts that depend on in vivo remodelling for tissue maturation. Especially, the efforts taken to construct a system complex enough to provide conditions that mimic the biochemical, physical and mechanical microenvironment of the native tissue need to be justified. Also, it has been suggested that biophysical stimulation probably results in effects that lead to tissue fibrosis when implanted (Carver and Goldsmith, 2013; Parvin Nejad et al., 2016) . Continued studies in this aspect can only further our understanding on the practical relevance of physiological biomimicry in bioreactors for clinical implantation. With regards to monitoring culture conditions, we are already close to adapting the currently available commercial modalities in clinical settings. Sensing provides us ways to ensure accuracy of the microenvironmental conditions for tissue growth, which is very important for subsequent clinical implantation. On the other hand, bioreactor-integrated imaging systems for real-time evaluation of tissue growth and development have not shown as much translation even to the commercial arena owing to the complexity and the costs involved. Despite being able to predict successful utilization of bioreactor in clinics by making suitable design modifications, there are limitations associated with the translation of laboratory-designed bioreactors into industrial-grade units for utility in the clinical setting. High financial costs incurred from research studies and the development of bioreactor systems, with increased complexity (i.e. automation, process control and sterilization systems), as well as the long wait-time for compliance with the regulations are the primary hurdles that hinder fast introduction of new bioreactor systems into the commercial and clinical scene. Good manufacturing practice (GMP) ensures quality assurance and control in accordance with the stringent guidelines throughout the development and production phases. The International Organization for Standardization (ISO) standards have also been introduced for companies to comply in design, manufacturing followed by subsequent product installation and validation. Over the years, the push factor for more stringent regulation has indirectly led to higher levels of technological advances such as automation, which helps in facilitating validation tests. Ultimately, the intent of having these tightened regulations is to achieve quality and safety in the final cell-cultured product. However, the long processing times may have resulted in the exit of non-validated bioreactor systems and is likely to be a long journey before the bioreactor will be adopted widespread in the clinical setting. The clinical implementation of bioreactors is expected to be faced with challenges to a certain extent, also due to the logistical set-up and the need for a strong team of well-trained and dedicated cGMP-certified personnel. In different geographical jurisdictions, the governmental requirements for cGMP, hospital layouts and flow processes differ. The need for sterility and long preparation time of bioreactor requires qualified and well-trained technical personnel. Issues like safety, scalability and ease of handling also need to be considered while designing bioreactor systems. Ultimately, the successful clinical utilization of the design strategies will depend on constant developments in our understanding of tissue-engineering approaches, identifying the relevant clinical needs and solving the logistical challenges in bringing bioreactors to clinics.
Conclusion
For effective utilization of laboratory research, scientists need to constantly work towards implementing the research successes in a hospital . With respect to bioreactor studies, we are still far from the era of widespread utility of bioreactors in the clinical setting. The key design factors highlighted in this article are worthy of consideration for future utility of these tissue culture systems in medicine. From an engineering point of view, the bioreactor technology has shown significant development over the years, with precise control of the various parameters of the microenvironment and real- time sensing and imaging facilities, which allow greater control and reproducibility of the tissue graft generation. In addition, closer interactions among clinicians, scientists, engineers and other stakeholders such as the regulatory bodies and industrial partners are required to integrate the various requirements needed for a clinically relevant bioreactor . The future trend of bioreactors lies in an approach directed towards the mimicry of physiological environment, which incorporates the key design considerations discussed in this review and is envisaged to be of effective clinical utility ( Figure   F3 3).
